Wolfgang Koch

Title: Wolfgang Koch: Innovator in Pharmaceutical Chemistry

Introduction

Wolfgang Koch is a notable inventor based in Riehen, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of hypoglycemic agents and compounds for blood pressure management. With a total of 2 patents, his work has had a meaningful impact on medical science.

Latest Patents

Koch's latest patents include "Benzazepinyl sulfonylureas and intermediates therefore," which describes sulfonylurea derivatives that are useful as hypoglycemic agents. Another significant patent is for "Dihydrocoumarin derivatives," which outlines a process for obtaining dihydroxy coumarin compounds that can lower blood pressure and facilitate chemical sympathectomy. These innovations showcase his commitment to advancing healthcare solutions.

Career Highlights

Wolfgang Koch has been associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work there has allowed him to focus on developing innovative compounds that address critical health issues. His expertise in pharmaceutical chemistry has positioned him as a valuable asset in the field.

Collaborations

Koch has collaborated with notable colleagues, including Ado Kaiser and Marcel Scheer. These partnerships have fostered an environment of innovation and have contributed to the successful development of his patented compounds.

Conclusion

Wolfgang Koch's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.